Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box

被引：18
|
作者：
Vanfleteren, Lowie E. G. W. [1 ]
Ullman, Anders [1 ]
Nordenson, Anita [1 ]
Andersson, Anders [1 ]
Andelid, Kristina [1 ]
Fabbri, Leonardo M. [1 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, COPD Ctr, Gothenburg, Sweden
来源：
ERJ OPEN RESEARCH | 2019年 / 5卷 / 01期
关键词：
OBSTRUCTIVE PULMONARY-DISEASE; DOUBLE-BLIND; FLUTICASONE FUROATE; INHALED BUDESONIDE; PARALLEL-GROUP; EXACERBATIONS; VILANTEROL; MODERATE; RISK; GLUCOCORTICOIDS;
D O I：
10.1183/23120541.00185-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [31] ICS+LABA、LAMA联用与单独使用ICS+LABA对COPD的疗效比较
    梁兴
    张明
    [J]. 热带医学杂志, 2019, 19 (09) : 1135 - 1138
  • [32] TRIPLE THERAPY (ICS/LABA/LAMA) IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Saleh, C.
    Kim, L.
    Whalen-Browne, A.
    Chu, D.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S37 - S38
  • [33] The Overrated Impact of Inhaled Substances (LABA, LAMA, ICS) on Exacerbation Rates in COPD
    Koehler, D.
    Dellweg, D.
    [J]. PNEUMOLOGIE, 2018, 72 (02): : 132 - 137
  • [34] Cost-effectiveness of a single inhaler triple therapy versus ICS/LABA in COPD
    Martin, Alan A.
    Shah, Dhvani
    Goodall, Emma C.
    Schroeder, Melanie
    Risebrough, Nancy
    Ndirangu, Kerigo
    Ismaila, Afisi S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [35] Ellithe: A prospective non-interventional Study to Assess the Quality of Life and Symptoms in COPD Patients receiving LAMA/LABA/ICS Triple Therapy
    Beeh, M. K.
    Scheithe, K.
    Brinkmann, R.
    [J]. PNEUMOLOGIE, 2022, 76 : S4 - S4
  • [36] Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
    Monteagudo, Monica
    Nunez, Alexa
    Barrecheguren, Miriam
    Miravitlles, Marc
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 699 - 707
  • [37] Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
    Aziz, Mohamed Ismail Abdul
    Tan, Ling Eng
    Wu, David Bin-Chia
    Pearce, Fiona
    Chua, Gerald Seng Wee
    Lin, Liang
    Tan, Ping-Tee
    Ng, Kwong
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3203 - 3231
  • [38] Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis
    Calzetta, Luigino
    Di Marco, Fabiano
    Blasi, Francesco
    Cazzola, Mario
    Centanni, Stefano
    Micheletto, Claudio
    Rossi, Andrea
    Rogliani, Paola
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 59
  • [39] Evaluating multiple eosinophil measurements when stepping up to ICS/LAMA/LABA triple therapy in patients with COPD: a post-hoc analysis of ETHOS
    Singh, D.
    Bafadhel, M.
    Hurst, J. R.
    Darken, P.
    Patel, M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [40] Single Inhaler Triple Therapy (ics/lama/laba) In Patients With Advanced COPD: Patient Reported Symptom And Inhaler Preference Results From The Fulfil Trial
    Tabberer, M.
    Lomas, D.
    Barnacle, H.
    Birk, R.
    Brealey, N.
    Zhu, C. -Q.
    Pascoe, S.
    Locantore, N.
    Lipson, D. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345